Physician profile
Patrick W Daly
NPI 1063480853
$7,257.15
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,036 · 2020: $2,524 · 2021: $1,651 · 2022: $46.41.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,804.03 | 2019-2021 | |
| Viiv Healthcare Company | $1,182.45 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $650.21 | 2019-2020 | |
| Janssen Biotech, INC. | $562.31 | 2019-2020 | |
| Gilead Sciences, INC. | $386.96 | 2019-2020 | |
| Novo Nordisk INC | $318.95 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $292.90 | 2019 | |
| Pfizer INC. | $228.03 | 2019-2020 | |
| Janssen Products, LP | $224.98 | 2019 | |
| Theratechnologies INC. | $192.84 | 2019-2020 | |
| Emd Serono, INC. | $189.76 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $137.44 | 2019-2020 | |
| Glaxosmithkline, LLC. | $110.71 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.64 | 2019-2020 | |
| Aytu Biopharma, INC. | $92.71 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $90.10 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.36 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.22 | 2019-2020 | |
| Abbvie INC. | $65.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $61.52 | 2019-2020 | |
| Allergan, INC. | $57.12 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $49.45 | 2019-2020 | |
| Organon LLC | $46.41 | 2022 | |
| Janssen Scientific Affairs, LLC | $27.80 | 2019 | |
| Antares Pharma, INC. | $26.38 | 2020 | |
| Jazz Pharmaceuticals INC. | $25.95 | 2021 | |
| Mannkind Corporation | $25.29 | 2020 | |
| Amarin Pharma, INC. | $24.65 | 2019 | |
| Astellas Pharma US INC | $21.08 | 2019 | |
| Eisai INC. | $20.72 | 2020 | |
| Napo Pharmaceuticals INC | $20.58 | 2019 | |
| Avanir Pharmaceuticals, INC. | $16.76 | 2019 | |
| Shire North American Group INC | $16.13 | 2019 | |
| Therapeuticsmd, INC. | $13.43 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Daly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.